The 2014 New Concepts Symposium featured seven presentations of embryonic research concepts.
Congratulations go to Dr Matthew Burge of Royal Brisbane Hospital for winning the Best of New Concepts Award for his concept ‘A randomised Phase 2/3 study of Infusional FU/LV with panitumumab V FU/LV/capecitabine with bevacizumab as first line therapy for never resectable, RAS and RAF wild type metastatic colorectal cancer’.